Study of a new injection for healthy volunteers
Part of Hormones & metabolism clinical trials.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 60 years
- Weigh at least 50 kg (about 110 pounds) and have a body mass index (BMI) between 18 and 35
- Weight stable (within 5%) for the past 3 months
- Willing to use effective birth control during the study and for 6 months after
- No significant health problems, including heart, liver, kidney, or mental health conditions
- No use of certain medications, herbal supplements, or recreational drugs before the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication (SYH2082) that works like GLP-1 and GIP drugs to see how safe it is and how your body handles it. You must be healthy with no diabetes, thyroid cancer risk, or recent major surgery.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.